EXEL
Exelixis, Inc.
🇺🇸 NYSE/NASDAQ
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 19.48%
Annual Growth
5 years average annual growth
🌏
6
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma (RCC), for previously treated hepatocellular carcinoma (HCC) and for previously treated, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). The Company's other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor (MR) approved the treatment of hypertension.
📈 Performance
Price History*
+2412.86%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$35.18
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EXEL
6
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
15 weeks
💵 Average investment amount
$647
⏰ Last time a customer invested in EXEL
9 days
EXEL investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
38%
50k - 100k
63%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
67%
35 - 90
33%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in EXEL also invest in...
🙌 Performance (5Yr p.a)
470.43%
📊 Share price
$137.34 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
1120.23%
📊 Share price
$191.96 USD
Want more shares? Try these...
